Faricimab for treating wet age-related macular degeneration [ID3898 ] In development [GID-TA10799]Expected publication date: TBC

DRAFT guidance recommends faricimab as an option for treating wet age-related macular degeneration in adults, only if certain ophthalmological criteria are met and the company provides faricimab according to the commercial arrangement.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news